Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

May 17, 2019
AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act.
May 8, 2019
AHA letter to Representative Kilmer expressing support of H.R. 2552, the “Protecting Local Access to Care for Everyone Act.” 
May 6, 2019
The AHA today expressed support for the Excellence in Mental Health and Addiction Treatment Expansion Act (H.R.1767/S. 824), bipartisan legislation that would renew and expand an innovative demonstration program that expands access to treatment of mental illnesses and substance use disorders through community-based clinics.
May 6, 2019
The AHA supports the administration’s goal of expanding access to coverage and increasing competition between health plans, but does not believe that efforts to facilitate the sale of insurance across state lines “will achieve either of those goals in a meaningful way,” the association said today, responding to a Centers for Medicare & Medicaid Services request for input on how to enhance insurers’ ability to sell individual health insurance across state lines.
May 2, 2019
AHA letter to Senator Richard J. Durbin expressing support of provisions of legislation, S. 916, the Mothers and Offspring Mortality and Morbidity Awareness (MOMMA’s) Act.
May 2, 2019
AHA letter to Representative Robin L. Kelly expressing support of provisions of legislation, H.R. 1897, the Mothers and Offspring Mortality and Morbidity Awareness (MOMMA’s) Act.
May 1, 2019
AHA comments on the Joint Commission’s recently proposed standards for perinatal safety.
May 1, 2019
AHA letter to Representative Brad Schneider expressing support for legislation, H.R. 2439, the Opioid Workforce Act of 2019,
May 1, 2019
AHA urges the Antitrust Division of the Department of Justice (“DOJ”) to investigate thoroughly Centen